Fluconazole in the Treatment of Hepatosplenic Candidiasis

Keyphrases

• Abdominal Pain 33%
• Acute Myeloid Leukemia 33%
• Alkaline Phosphatase Level 33%
• Amphotericin B 66%
• Antibiotic Therapy 33%
• Broad-spectrum Antibiotics 33%
• Candida Species 33%
• Elevated Alkaline Phosphatase 33%
• Enzyme Level 33%
• Fluconazole 100%
• Gastrointestinal mucosal Damage 33%
• Hematological Malignancies 33%
• Hepatic Enzymes 33%
• Hepatosplenic Candidiasis 100%
• Immunocompromised Host 33%
• Intensive Chemotherapy 66%
• Less Toxic 33%
• Mortality Rate 33%
• Out of Proportion 33%
• Persistent Fever 33%
• Portal Vein 33%
• Prolonged Course 33%
• Prolonged Neutropenia 33%
• Prolonged Treatment 33%
• Risk Factors 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Abdominal Pain 33%
• Acute Myeloid Leukemia 33%
• Alkaline Phosphatase 33%
• Amphotericin B 66%
• Antibiotic Agent 33%
• Antibiotic Therapy 33%
• Candida 33%
• Candidiasis 100%
• Chemotherapy 66%
• Fluconazole 100%
• Hematologic Malignancy 33%
• Immunocompromised Patient 33%
• Liver Enzyme 33%
• Mortality Rate 33%
• Neutropenia 33%

Medicine and Dentistry

• Abdominal Pain 33%
• Acute Myeloid Leukemia 33%
• Amphotericin B 66%
• Antibiotic Therapy 33%
• Broad-Spectrum Antibiotic 33%
• Candidiasis 100%
• Elevated Alkaline Phosphatase 33%
• Fluconazole 100%
• Hematologic Malignancy 33%
• Hepatic Portal Vein 33%
• Immunocompromised Patient 33%
• Liver Enzyme 33%
• Mortality Rate 33%
• Neutropenia 33%
• Persistent Pain 33%